ContraFect Corporation's Universal Influenza Treatment Receives SBIR Funding
September 16, 2014 07:30 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Sep 16, 2014) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW) (NASDAQ: CFRXZ), a biotechnology company focused on the discovery and development of protein...
ContraFect Corporation Announces Separation of Units Sold in IPO
September 09, 2014 07:30 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Sep 9, 2014) - ContraFect Corporation (NASDAQ: CFRXU), a biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious...
ContraFect Corporation to Present at the Rodman & Renshaw 16th Annual Healthcare Conference
September 03, 2014 07:30 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Sep 3, 2014) - ContraFect Corporation (NASDAQ: CFRXU), a biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious...
ContraFect Corporation Showcases CF-301 at ICAAC 2014 Meeting in Washington, D.C.
September 02, 2014 17:00 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Sep 2, 2014) - ContraFect Corporation (NASDAQ: CFRXU), a biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious...
ContraFect Corporation Announces Exercise of Initial Public Offering Over-Allotment Option
August 27, 2014 17:00 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Aug 27, 2014) - ContraFect Corporation (NASDAQ: CFRXU), a biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious...
ContraFect Corporation Announces Closing of Initial Public Offering
August 04, 2014 07:30 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Aug 4, 2014) - ContraFect Corporation (NASDAQ: CFRXU), a biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious...
ContraFect Announces Pricing of Its Initial Public Offering
July 29, 2014 07:30 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Jul 29, 2014) - ContraFect Corporation (NASDAQ: CFRXU), a biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious...
Journal of Infectious Diseases Publishes ContraFect Corporation's Scientific Research
May 13, 2014 08:00 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - May 13, 2014) - ContraFect Corporation, a biotechnology company focused on discovering and developing therapeutic protein and antibody products for life-threatening,...
ContraFect Corporation Confirms Appointment of Julia P. Gregory as CEO and Director, and Appoints David N. Low, Michael J. Otto and Roger J. Pomerantz to Board of Directors
April 24, 2014 08:00 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Apr 24, 2014) - ContraFect Corporation, a leader in the discovery and development of protein therapeutics and antibody products for life-threatening, drug-resistant...
ContraFect Corporation to Present at 12th Annual BIO Investor Forum
October 01, 2013 09:13 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - Oct 1, 2013) - ContraFect Corporation announced that Dr. Robert Nowinski, the company's founder and chief executive officer, and Julia P. Gregory, the company's...